These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 16894028)
1. Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions. Wise-Draper TM; Allen HV; Jones EE; Habash KB; Matsuo H; Wells SI Mol Cell Biol; 2006 Oct; 26(20):7506-19. PubMed ID: 16894028 [TBL] [Abstract][Full Text] [Related]
2. The human DEK proto-oncogene is a senescence inhibitor and an upregulated target of high-risk human papillomavirus E7. Wise-Draper TM; Allen HV; Thobe MN; Jones EE; Habash KB; Münger K; Wells SI J Virol; 2005 Nov; 79(22):14309-17. PubMed ID: 16254365 [TBL] [Abstract][Full Text] [Related]
3. DEK promotes HPV-positive and -negative head and neck cancer cell proliferation. Adams AK; Hallenbeck GE; Casper KA; Patil YJ; Wilson KM; Kimple RJ; Lambert PF; Witte DP; Xiao W; Gillison ML; Wikenheiser-Brokamp KA; Wise-Draper TM; Wells SI Oncogene; 2015 Feb; 34(7):868-77. PubMed ID: 24608431 [TBL] [Abstract][Full Text] [Related]
4. DEK proto-oncogene expression interferes with the normal epithelial differentiation program. Wise-Draper TM; Morreale RJ; Morris TA; Mintz-Cole RA; Hoskins EE; Balsitis SJ; Husseinzadeh N; Witte DP; Wikenheiser-Brokamp KA; Lambert PF; Wells SI Am J Pathol; 2009 Jan; 174(1):71-81. PubMed ID: 19036808 [TBL] [Abstract][Full Text] [Related]
5. Melanoma proliferation and chemoresistance controlled by the DEK oncogene. Khodadoust MS; Verhaegen M; Kappes F; Riveiro-Falkenbach E; Cigudosa JC; Kim DS; Chinnaiyan AM; Markovitz DM; Soengas MS Cancer Res; 2009 Aug; 69(16):6405-13. PubMed ID: 19679545 [TBL] [Abstract][Full Text] [Related]
6. DEK proto-oncogene is highly expressed in astrocytic tumors and regulates glioblastoma cell proliferation and apoptosis. Feng T; Liu Y; Li C; Li Z; Cai H Tumour Biol; 2017 Jul; 39(7):1010428317716248. PubMed ID: 28670979 [TBL] [Abstract][Full Text] [Related]
7. Progress in studies on the DEK protein and its involvement in cellular apoptosis. Hua Y; Hu H; Peng X Sci China C Life Sci; 2009 Jul; 52(7):637-42. PubMed ID: 19641868 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms underlying cancer growth and apoptosis by DEK overexpression in colorectal cancer. Lin L; Piao J; Ma Y; Jin T; Quan C; Kong J; Li Y; Lin Z PLoS One; 2014; 9(10):e111260. PubMed ID: 25340858 [TBL] [Abstract][Full Text] [Related]
9. The oncoprotein DEK affects the outcome of PARP1/2 inhibition during mild replication stress. Ganz M; Vogel C; Czada C; Jörke V; Gwosch EC; Kleiner R; Pierzynska-Mach A; Zanacchi FC; Diaspro A; Kappes F; Bürkle A; Ferrando-May E PLoS One; 2019; 14(8):e0213130. PubMed ID: 31408463 [TBL] [Abstract][Full Text] [Related]
10. Caspase-dependent apoptosis induction by targeted expression of DEK in Drosophila involves histone acetylation inhibition. Lee KS; Kim DW; Kim JY; Choo JK; Yu K; Seo SB J Cell Biochem; 2008 Mar; 103(4):1283-93. PubMed ID: 17685435 [TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of apoptosis related proteins regulated by proto-oncogene protein DEK. Kim DW; Chae JI; Kim JY; Pak JH; Koo DB; Bahk YY; Seo SB J Cell Biochem; 2009 Apr; 106(6):1048-59. PubMed ID: 19229864 [TBL] [Abstract][Full Text] [Related]
12. SiRNA knockdown of the DEK nuclear protein mRNA enhances apoptosis and chemosensitivity of canine transitional cell carcinoma cells. Yamazaki H; Iwano T; Otsuka S; Kagawa Y; Hoshino Y; Hosoya K; Okumura M; Takagi S Vet J; 2015 Apr; 204(1):60-5. PubMed ID: 25773167 [TBL] [Abstract][Full Text] [Related]
13. IRAK1 is a novel DEK transcriptional target and is essential for head and neck cancer cell survival. Adams AK; Bolanos LC; Dexheimer PJ; Karns RA; Aronow BJ; Komurov K; Jegga AG; Casper KA; Patil YJ; Wilson KM; Starczynowski DT; Wells SI Oncotarget; 2015 Dec; 6(41):43395-407. PubMed ID: 26527316 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of the cellular DEK protein promotes epithelial transformation in vitro and in vivo. Wise-Draper TM; Mintz-Cole RA; Morris TA; Simpson DS; Wikenheiser-Brokamp KA; Currier MA; Cripe TP; Grosveld GC; Wells SI Cancer Res; 2009 Mar; 69(5):1792-9. PubMed ID: 19223548 [TBL] [Abstract][Full Text] [Related]
15. Expression level of DEK in chronic lymphocytic leukemia is regulated by fludarabine and Nutlin-3 depending on p53 status. Wang DM; Liu L; Fan L; Zou ZJ; Zhang LN; Yang S; Li JY; Xu W Cancer Biol Ther; 2012 Dec; 13(14):1522-8. PubMed ID: 23052131 [TBL] [Abstract][Full Text] [Related]
16. The human oncoprotein and chromatin architectural factor DEK counteracts DNA replication stress. Deutzmann A; Ganz M; Schönenberger F; Vervoorts J; Kappes F; Ferrando-May E Oncogene; 2015 Aug; 34(32):4270-7. PubMed ID: 25347734 [TBL] [Abstract][Full Text] [Related]
17. The involvement of cellular proliferation status in the expression of the human proto-oncogene DEK. Ageberg M; Gullberg U; Lindmark A Haematologica; 2006 Feb; 91(2):268-9. PubMed ID: 16461319 [TBL] [Abstract][Full Text] [Related]
18. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. Rampias T; Sasaki C; Weinberger P; Psyrri A J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448 [TBL] [Abstract][Full Text] [Related]
19. The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival. Hacker KE; Bolland DE; Tan L; Saha AK; Niknafs YS; Markovitz DM; McLean K Neoplasia; 2018 Dec; 20(12):1209-1218. PubMed ID: 30412857 [TBL] [Abstract][Full Text] [Related]
20. The DEK oncoprotein and its emerging roles in gene regulation. Sandén C; Gullberg U Leukemia; 2015 Aug; 29(8):1632-6. PubMed ID: 25765544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]